Authors

• Javier Armisen
• Benjamin Challis (ORCID: https://orcid.org/0000-0002-1130-2851)
• Mikael Sunnåker (ORCID: https://orcid.org/0009-0003-5881-4998)
• Karin Nelander (ORCID: https://orcid.org/0000-0002-2649-1130)
• Umberto Vespasiani‐Gentilucci (ORCID: https://orcid.org/0000-0002-1138-1967)
• Armando W. Flor
• Debra Carter
• Malin Aurell
• Chandrali Bhattacharya (ORCID: https://orcid.org/0000-0002-3224-1306)
• Carl Whatling
• John Eriksson (ORCID: https://orcid.org/0000-0001-7028-0069)
• Monika Trebski
• Emma Gårdmark

Institutions

• AstraZeneca (United Kingdom) (GB)
• Università Campus Bio-Medico (IT)
• AstraZeneca (South Korea) (KR)
• AstraZeneca (Poland) (PL)
• AstraZeneca (Finland) (FI)
• Campus Bio Medico University Hospital (IT)
• AstraZeneca (Sweden) (SE)
• AstraZeneca (United States) (US)
• AstraZeneca (Germany) (DE)

Publication Details

Journal

Liver International

Published

2025-10-18

DOI

https://doi.org/10.1111/liv.70406

Citations

2

Primary Topic

Liver Disease Diagnosis and Treatment

Type

article

Field-Weighted Citation Impact

2.71

Funders

• AstraZeneca